Get the Stockscreener App
4.57
0.88%
0.04
After Hours:
4.55
-0.02
-0.44%
Candel Therapeutics Inc Stock (CADL) Forecast
The Candel Therapeutics Inc (CADL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.212, representing a +14.05% increase from the current price of $4.57. The highest analyst price target is $5.7921, and the lowest is $4.632.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CADL Price Target
Average 4.6054
(+0.77% Upside)
Is Candel Therapeutics Inc (CADL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 32.96 | Neutral |
| STOCH(9,6) | 43.32 | Neutral |
| STOCHRSI(14) | 68.34 | Neutral |
| MACD(12,26) | -0.875 | Sell |
| ADX(14) | 34.82 | Sell |
| William %R | -80.55 | Buy |
| CCI(14) | -18.26 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.811
Sell
|
5.0015
Sell
|
| MA20 |
5.7613
Sell
|
5.6715
Sell
|
| MA50 |
7.6022
Sell
|
6.7339
Sell
|
| MA100 |
7.3038
Sell
|
6.9577
Sell
|
| MA200 |
6.6193
Sell
|
6.4438
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CADL could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 12 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on CADL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.96 indicates that CADL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 43.32 indicates that CADL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 68.34 indicates that CADL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.82 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -18.26 indicates that CADL is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CADL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Candel Therapeutics Inc financial reports and earnings history, Candel Therapeutics Inc (CADL) stock could reach $5.151 by 2030, $21.23 by 2040 and $20.51 by 2050. See the projected annual prices until 2050 of the Candel Therapeutics Inc stock below:
- Candel Therapeutics Inc (CADL) is expected to reach an average price of $9.3086 in 2035, with a high prediction of $9.8843 and a low estimate of $8.9975. This indicates an $103.69% rise from the last recorded price of $4.57.
- Candel Therapeutics Inc (CADL) stock is projected to chart a bullish course in 2040, with an average price target of $20.13, representing an $340.39% surge from its current level. The forecast ranges from a conservative $19.52 to a sky-high $21.23.
- Our analysts predict Candel Therapeutics Inc (CADL) to jump 234.14% by 2045, soaring from $15.05 to an average price of $15.27, potentially reaching $15.63. While $15.05 is the low estimate, the potential upside is significant.
- Candel Therapeutics Inc (CADL) stock is expected to climb by 2050, reaching an average of $20.51, a $348.90% jump from its current level. However, a wide range of estimates exists, with high and low targets of $20.51 and $19.28, respectively, highlighting the market's uncertainty.
Candel Therapeutics Inc Stock (CADL) Year by Year Forecast
Candel Therapeutics Inc Stock (CADL) Price Forecast for 2025
Candel Therapeutics Inc Stock (CADL) is expected to reach an average price of $5.4237 in 2025, with a high prediction of $7.5434 and a low estimate of $3.304. This indicates an +18.68% rise from the last recorded price of $4.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $5.0321 | $4.632 | $5.7921 | +10.11% |
| June, 2025 | $5.3032 | $4.8404 | $5.6932 | +16.04% |
| July, 2025 | $5.107 | $4.9842 | $6.107 | +11.75% |
| August, 2025 | $4.408 | $4.388 | $5.4698 | -3.54% |
| September, 2025 | $3.4291 | $3.3508 | $4.5808 | -24.96% |
| October, 2025 | $3.7729 | $3.3519 | $3.8829 | -17.44% |
| November, 2025 | $3.694 | $3.304 | $4.7685 | -19.17% |
| December, 2025 | $4.4873 | $3.5095 | $4.9751 | -1.81% |
Candel Therapeutics Inc Stock (CADL) Price Forecast for 2026
The predicted value for Candel Therapeutics Inc (CADL) in 2026 is set at an average of $3.6114. Estimates vary from a peak of $4.5206 to a trough of $2.7023, indicating an -20.98% surge from the present price of $4.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.8889 | $3.7889 | $4.5206 | -14.90% |
| February, 2026 | $3.37 | $3.36 | $4.0217 | -26.26% |
| March, 2026 | $3.371 | $3.241 | $3.561 | -26.24% |
| April, 2026 | $3.5348 | $3.1038 | $3.8221 | -22.65% |
| May, 2026 | $3.4459 | $3.4059 | $3.7759 | -24.60% |
| June, 2026 | $3.227 | $3.127 | $3.6886 | -29.39% |
| July, 2026 | $3.0508 | $2.9721 | $3.2825 | -33.24% |
| August, 2026 | $3.2319 | $3.0036 | $3.3791 | -29.28% |
| September, 2026 | $2.9457 | $2.8957 | $3.3083 | -35.54% |
| October, 2026 | $2.9365 | $2.854 | $3.254 | -35.74% |
| November, 2026 | $2.9478 | $2.7023 | $3.205 | -35.50% |
| December, 2026 | $3.4016 | $2.8289 | $3.5216 | -25.57% |
Candel Therapeutics Inc Stock (CADL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Candel Therapeutics Inc (CADL) is $10.62, with a high forecast of $18.16 and a low forecast of $3.0844. This indicates an +132.46% increase from the last price of $4.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.4027 | $3.0844 | $3.5699 | -25.54% |
| February, 2027 | $3.3838 | $3.2382 | $3.4682 | -25.96% |
| March, 2027 | $3.7976 | $3.2965 | $4.0448 | -16.90% |
| April, 2027 | $3.6886 | $3.4459 | $3.8431 | -19.29% |
| May, 2027 | $8.5097 | $3.6714 | $13.51 | +86.21% |
| June, 2027 | $11.41 | $8.3026 | $11.57 | +149.70% |
| July, 2027 | $13.32 | $10.49 | $18.16 | +191.54% |
| August, 2027 | $13.30 | $12.69 | $14.41 | +190.93% |
| September, 2027 | $14.31 | $12.83 | $15.41 | +213.19% |
| October, 2027 | $12.29 | $11.77 | $14.45 | +168.82% |
| November, 2027 | $10.24 | $9.5361 | $12.18 | +124.01% |
| December, 2027 | $7.6749 | $7.5149 | $10.57 | +67.94% |
Candel Therapeutics Inc Stock (CADL) Price Forecast for 2028
In 2028, Candel Therapeutics Inc (CADL) is projected to reach an average price of $7.2792, with a high projection of $9.3368 and a low estimate of $5.2216. This indicates an +59.28% rise from the last price of $4.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.657 | $7.0204 | $8.5915 | +67.55% |
| February, 2028 | $8.1091 | $7.1036 | $9.0091 | +77.44% |
| March, 2028 | $8.4668 | $7.7846 | $9.3368 | +85.27% |
| April, 2028 | $7.1189 | $6.9334 | $8.5923 | +55.77% |
| May, 2028 | $7.1065 | $6.6344 | $7.8655 | +55.50% |
| June, 2028 | $6.9987 | $6.4585 | $7.5121 | +53.14% |
| July, 2028 | $7.0458 | $6.6808 | $7.6242 | +54.17% |
| August, 2028 | $7.7884 | $6.8384 | $7.9584 | +70.43% |
| September, 2028 | $6.7306 | $6.7306 | $7.964 | +47.28% |
| October, 2028 | $5.6927 | $5.2216 | $6.8761 | +24.57% |
| November, 2028 | $5.5303 | $5.2338 | $5.7463 | +21.01% |
| December, 2028 | $5.3225 | $5.2825 | $6.6669 | +16.47% |
Candel Therapeutics Inc Stock (CADL) Price Forecast for 2029
The 2029 price forecast for Candel Therapeutics Inc Stock (CADL) is $5.8173 on average, with a high prediction of $6.8901 and a low estimate of $4.7445. This represents an +27.29% increase from the previous price of $4.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.5001 | $5.208 | $6.8901 | +42.23% |
| February, 2029 | $5.9522 | $5.7522 | $6.4757 | +30.25% |
| March, 2029 | $5.4944 | $5.4944 | $6.1578 | +20.23% |
| April, 2029 | $5.2865 | $5.1854 | $5.5198 | +15.68% |
| May, 2029 | $5.4741 | $5.0576 | $5.7841 | +19.78% |
| June, 2029 | $5.4763 | $5.3852 | $5.6497 | +19.83% |
| July, 2029 | $5.2284 | $5.1429 | $5.7518 | +14.41% |
| August, 2029 | $5.076 | $4.9673 | $5.275 | +11.07% |
| September, 2029 | $5.3132 | $4.9866 | $5.3882 | +16.26% |
| October, 2029 | $5.1858 | $5.1548 | $5.3337 | +13.48% |
| November, 2029 | $4.968 | $4.888 | $5.334 | +8.71% |
| December, 2029 | $4.9931 | $4.7445 | $5.2501 | +9.26% |
Candel Therapeutics Inc Stock (CADL) Price Forecast for 2030
Candel Therapeutics Inc Stock (CADL) is expected to reach an average price of $12.37 in 2030, with a high forecast of $19.85 and a low forecast of $4.8877. This signifies an +170.69% surge from the last price of $4.57.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.0177 | $4.8877 | $5.151 | +9.80% |
| February, 2030 | $5.5499 | $4.9333 | $5.6399 | +21.44% |
| March, 2030 | $5.462 | $5.3164 | $5.5953 | +19.52% |
| April, 2030 | $5.9341 | $5.383 | $6.1186 | +29.85% |
| May, 2030 | $5.7118 | $5.5518 | $6.1396 | +24.98% |
| June, 2030 | $9.4039 | $5.6673 | $15.62 | +105.77% |
| July, 2030 | $13.05 | $9.3394 | $13.20 | +185.52% |
| August, 2030 | $12.92 | $12.70 | $19.85 | +182.75% |
| September, 2030 | $15.78 | $12.19 | $16.11 | +245.29% |
| October, 2030 | $16.19 | $14.39 | $17.12 | +254.29% |
| November, 2030 | $14.59 | $14.31 | $16.21 | +219.24% |
| December, 2030 | $13.04 | $11.27 | $15.05 | +185.39% |
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):